Yu Wan

Dr. Yu Wan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2014 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
LHLiu He
Liu He
YZYong Zheng
Yong Zheng
YWYu Wan
Yu Wan
JSJian Song
Jian Song

21 January 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
Teng JiangTeng Jiang
Teng Jiang
YWYu Wan
Yu Wan
JZJun-Shan Zhou
Jun-Shan Zhou
MTMeng-Shan Tan
Meng-Shan Tan
QHQing Huang
Qing Huang
JYJintai Yu
Jintai Yu

13 July 2009 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
HWHui Wu
Hui Wu
YWYu Wan
Yu Wan
CXChen Xiumei
Chen Xiumei
CCCai‐Fa Chen
Cai‐Fa Chen
LLLeilei Lu
Leilei Lu
CYCai‐Hui Yue
Cai‐Hui Yue

1 May 2013 in Letters in Organic Chemistry
Verified
Journal Article
Closed access
PDF file
LZLing-Ling Zhaoa
Ling-Ling Zhaoa
YWYu Wan
Yu Wan
SHShu-Ying Huang
Shu-Ying Huang
BDBo Dai
Bo Dai
LCLiang-Feng Chen
Liang-Feng Chen
HWHui Wu
Hui Wu
Silica sulfuric acid (SSA) was firstly used as an efficient catalyst to promote the synthesis of rctt configurational calix[4]resorcinarenes via one-pot condensation between resorcinol and aromatic aldehydes. The structure of 4- cyanophenyl-calix[4]resorcinarene (3b) has been determined by single crystal X-ray diffraction.

17 June 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
JZJing-Yu Zheng
Jing-Yu Zheng
HWHui-Fu Wang
Hui-Fu Wang
YWYu Wan
Yu Wan
MTMeng-Shan Tan
Meng-Shan Tan
CTChen-Chen Tan
Chen-Chen Tan
JYJintai Yu
Jintai Yu

1 January 2023 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LZLiwen Zhang
Liwen Zhang
ZHZhiying Huang
Zhiying Huang
FWFei Wang
Fei Wang
MXMei Xue
Mei Xue
XZXiaoyu Zhang
Xiaoyu Zhang
LMLiang Ma
Liang Ma
Background. Respiratory syncytial virus (RSV) is the main pathogen causing acute bronchiolitis, which is common in infants and young children. A previous study revealed the possible involvement of POU class 2 associating factor 1 (POU2AF1) in RSV‐triggered acute bronchiolitis. We attempted to clarify the specific action mechanism of POU2AF1 underlying RSV‐triggered inflammation. Methods. RT‐qPCR measured POU2AF1 levels in RSV‐infected children, mice, and airway epithelial cell lines (HBECs). HE staining showed histopathological features in the lung tissue of RSV‐infected mice. ELISA examined the contents of proinflammatory cytokines in RSV‐infected mice. Western blotting evaluated the protein abundance of proinflammatory cytokines in RSV‐infected HBECs and assessed NF‐κB pathway‐associated protein expression in RSV‐infected mice and RSV‐treated HBECs. Results. POU2AF1 presented depletion in RSV‐infected children, mice, and HBECs. RSV‐infected triggered lung injury and inflammatory cell infiltration in the mouse lung tissue, while POU2AF1 overexpression rescued these changes. RSV‐infected induced inflammatory impairment in HBECs, whereas POU2AF1 reversed this effect. POU2AF1 suppressed the upregulated NF‐κB pathway‐associated protein expression in mice and HBECs under RSV infection. Conclusion. POU2AF1 exerts a protective impact on RSV‐induced acute bronchiolitis in vitro and in vivo through the NF‐κB pathway. Our research may provide a novel direction for better therapy of RSV‐triggered acute bronchiolitis.